ArticleCureus2025
A Single-Center 11-Year Experience of Surgical Management of Breast Cancer in Patients Aged 90 Years or Older.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Surgery as a curative option for breast cancer is only offered to a fraction of women aged ≥90 years due to the lack of evidence supporting use of surgery in this patient group. This retrospective cohort study was undertaken to review patient outcomes following surgical treatment for breast cancer among women aged ≥ 90 years within our unit. Methods Retrospective case notes review and collection of clinicopathological data on 34 patients aged ≥ 90 years with early breast cancer who had surgery between 7th June 2007 and 31st July 2018 were carried out. Overall survival and disease-free survival were estimated using Kaplan-Meier survival analysis, with significance set to p <0.05. Results The median age of patients in the study was 90 years (range=90-101 years). The patients in this study were clinically fit and had Eastern Cooperative Oncology Group (ECOG) performance scores of 1 (67.6%) and 2 (32.4%). The mean tumour size was 33 mm (range=5-110mm). A total of 28 patients (82.3%) underwent a mastectomy, two (5.8%) of which were bilateral. Six patients (17.6%) had a wide local excision, 13 axillary lymph node clearances were performed at the primary surgery, and none of the patients in the study developed any major post-operative complications. A total of 25 patients (73.5%) had adjuvant endocrine therapy, and ten (29.4%) required adjuvant radiotherapy. None of the patients received adjuvant chemotherapy. Over a median follow-up of 6.2 years, eight patients (26.4%) developed recurrence of disease, and 24 (70.5%) patients died at the time of data collection. Mean disease-free survival was 96.7 months (95% CI, 80.3- 113.2 months), and mean overall survival was estimated to be 68.5 months (95% CI, 35-84 months). Conclusions Breast cancer surgery is safe with minimal complications in medically fit women aged ≥ 90 years with early non-metastatic breast cancer and offers good local control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.